183 related articles for article (PubMed ID: 28782880)
21. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
22. Detrusor wall thickness as a test for detrusor overactivity in women.
Lekskulchai O; Dietz HP
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):535-9. PubMed ID: 18634113
[TBL] [Abstract][Full Text] [Related]
23. The 3D structure of the human urinary bladder mucosa: a scanning electron microscopy study.
Congiu T; Radice R; Raspanti M; Reguzzoni M
J Submicrosc Cytol Pathol; 2004 Jan; 36(1):45-53. PubMed ID: 15311674
[TBL] [Abstract][Full Text] [Related]
24. Identification of different phenotypes of interstitial cells in the upper and deep lamina propria of the human bladder dome.
Gevaert T; Vanstreels E; Daelemans D; Franken J; Van Der Aa F; Roskams T; De Ridder D
J Urol; 2014 Nov; 192(5):1555-63. PubMed ID: 24893312
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound measurement of bladder wall thickness in the assessment of voiding dysfunction.
Blatt AH; Titus J; Chan L
J Urol; 2008 Jun; 179(6):2275-8; discussion 2278-9. PubMed ID: 18423703
[TBL] [Abstract][Full Text] [Related]
26. Gabapentin treatment of neurogenic overactive bladder.
Carbone A; Palleschi G; Conte A; Bova G; Iacovelli E; Bettolo CM; Pastore A; Inghilleri M
Clin Neuropharmacol; 2006; 29(4):206-14. PubMed ID: 16855422
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity.
Conte A; Giannantoni A; Proietti S; Giovannozzi S; Fabbrini G; Rossi A; Porena M; Berardelli A
Eur J Neurol; 2012 May; 19(5):725-32. PubMed ID: 22212295
[TBL] [Abstract][Full Text] [Related]
28. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.
Mansfield KJ; Liu L; Moore KH; Vaux KJ; Millard RJ; Burcher E
BJU Int; 2007 Jun; 99(6):1433-8. PubMed ID: 17428242
[TBL] [Abstract][Full Text] [Related]
30. Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.
Radziszewski P; Crayton R; Zaborski J; Członkowska A; Borkowski A; Bossowska A; Majewski M
Mult Scler; 2009 Jul; 15(7):860-8. PubMed ID: 19542265
[TBL] [Abstract][Full Text] [Related]
31. Systemic atherosclerosis causes detrusor overactivity: functional and morphological changes in hyperlipoproteinemic apoE-/-LDLR-/- mice.
Bschleipfer T; Dannenmaier AK; Illig C; Kreisel M; Gattenlöhner S; Langheinrich AC; Krombach GA; Weidner W; Kampschulte M
J Urol; 2015 Jan; 193(1):345-51. PubMed ID: 25171907
[TBL] [Abstract][Full Text] [Related]
32. Computer-assisted three-dimensional tracking of sensory innervation in the murine bladder mucosa with two-photon microscopy.
Schueth A; Spronck B; van Zandvoort MAMJ; van Koeveringe GA
J Chem Neuroanat; 2017 Nov; 85():43-49. PubMed ID: 28668578
[TBL] [Abstract][Full Text] [Related]
33. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
Haferkamp A
Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
[No Abstract] [Full Text] [Related]
34. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
Liu HT; Chancellor MB; Kuo HC
Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
[TBL] [Abstract][Full Text] [Related]
35. Telocytes in normal and keratoconic human cornea: an immunohistochemical and transmission electron microscopy study.
Marini M; Mencucci R; Rosa I; Favuzza E; Guasti D; Ibba-Manneschi L; Manetti M
J Cell Mol Med; 2017 Dec; 21(12):3602-3611. PubMed ID: 28714595
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic treatment of vesicoureteral reflux with non-simultaneous involuntary detrusor contraction in chronic spinal cord injury patients with neurogenic detrusor overactivity.
Vírseda MC; Salinas JC; Bolufer E; Esteban MF
Urol Int; 2014; 93(4):399-402. PubMed ID: 24642572
[TBL] [Abstract][Full Text] [Related]
37. Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.
Haab F
Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S2-5. PubMed ID: 25042138
[TBL] [Abstract][Full Text] [Related]
38. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
Cruz F; Nitti V
Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S26-31. PubMed ID: 25042140
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia.
Chen CY; Liao CH; Kuo HC
Spinal Cord; 2011 May; 49(5):659-64. PubMed ID: 21243000
[TBL] [Abstract][Full Text] [Related]
40. The oral mucosa: Epithelial professional phagocytes, lymphatics, telocytes, and false telocytes.
Butucescu M; Crăiţoiu Ş; Mogoantă L; Rusu MC; Iacov-Crăiţoiu MM; Stoenescu MD
Ann Anat; 2020 May; 229():151462. PubMed ID: 31978570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
